Physician profile
Tejas B Tripathi
NPI 1831406461
$656.20
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $32.61 · 2023: $23.91 · 2024: $20.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $200.04 | 2019 | |
| Amgen INC. | $72.36 | 2019 | |
| Exact Sciences Corporation | $44.39 | 2023-2024 | Cologuard Collection Kit |
| Philips North America LLC | $43.15 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $42.66 | 2019 | |
| Allergan, INC. | $41.70 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.26 | 2019 | |
| Merck Sharp & Dohme LLC | $29.83 | 2019 | |
| Novo Nordisk INC | $25.05 | 2019 | |
| Abbvie INC. | $18.22 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.43 | 2019 | |
| Shire North American Group INC | $16.09 | 2019 | |
| Astellas Pharma US INC | $16.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.29 | 2019 | |
| Glaxosmithkline, LLC. | $14.32 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.42 | 2019 | |
| Amarin Pharma, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejas Tripathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.